Top

Archives of Gynecology and Obstetrics

Published in:

01-08-2013 | General Gynecology

Bronchopulmonary dysplasia: a review

Authors: Zarqa Ali, Peter Schmidt, James Dodd, Dorthe Lisbeth Jeppesen

Published in: Archives of Gynecology and Obstetrics | Issue 2/2013

Abstract

Introduction

The prevalence of bronchopulmonary dysplasia (BPD), one of the most frequently occurring complications following preterm birth, is increasing due to increased survival of preterm infants.

Methods

Systematic literature review.

Conclusion

The etiology is multifactorial, with prematurity being a prerequisite for the development of BPD. Over time, there have been many different and new treatment modalities, some of them have reduced the severity of the disease, but none of them have been able to impact upon the increasing incidence of BPD.

Goldenberg RL, Culhane JF, Iams JD, Romero R (2008) Epidemiology and causes of preterm birth. Lancet 371:75–84PubMedCrossRef

Iams JD, Romero R, Culhane JF, Goldenberg RL (2008) Primary, secondary, and tertiary interventions to reduce the morbidity and mortality of preterm birth. Lancet 371:164–175PubMedCrossRef

Zeitlin J, Ancel PY, Delmas D, Breart G, Papiernik E (2010) Changes in care and outcome of very preterm babies in the Parisian region between 1998 and 2003. Arch Dis Child Fetal Neonatal Ed 95:F188–F193PubMedCrossRef

Doyle LW (2004) Evaluation of neonatal intensive care for extremely low birth weight infants in Victoria over two decades: I. effectiveness. Pediatrics 113:505–509PubMedCrossRef

Walsh MC, Szefler S, Davis J, Allen M, Van ML, Abman S, Blackmon L, Jobe A (2006) Summary proceedings from the bronchopulmonary dysplasia group. Pediatrics 117:S52–S56PubMed

Goldenberg RL, Jobe AH (2001) Prospects for research in reproductive health and birth outcomes. JAMA 285:633–639PubMedCrossRef

Northway WH Jr, Rosan RC, Porter DY (1967) Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med 276:357–368PubMedCrossRef

Bancalari E, Abdenour GE, Feller R, Gannon J (1979) Bronchopulmonary dysplasia: clinical presentation. J Pediatr 95:819–823PubMedCrossRef

Rojas MA, Gonzalez A, Bancalari E, Claure N, Poole C, Silva-Neto G (1995) Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease. J Pediatr 126:605–610PubMedCrossRef

10.

Avery ME, Tooley WH, Keller JB, Hurd SS, Bryan MH, Cotton RB, Epstein MF, Fitzhardinge PM, Hansen CB, Hansen TN (1987) Is chronic lung disease in low birth weight infants preventable? A survey of eight centers. Pediatrics 79:26–30PubMed

11.

Shennan AT, Dunn MS, Ohlsson A, Lennox K, Hoskins EM (1988) Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. Pediatrics 82:527–532PubMed

12.

Jobe AH, Bancalari E (2001) Bronchopulmonary dysplasia. Am J Respir Crit Care Med 163:1723–1729PubMedCrossRef

13.

Walsh MC, Wilson-Costello D, Zadell A, Newman N, Fanaroff A (2003) Safety, reliability, and validity of a physiologic definition of bronchopulmonary dysplasia. J Perinatol 23:451–456PubMedCrossRef

14.

Farstad T, Bratlid D, Medbo S, Markestad T (2011) Bronchopulmonary dysplasia—prevalence, severity and predictive factors in a national cohort of extremely premature infants. Acta Paediatr 100:53–58PubMedCrossRef

15.

Qiu X, Lodha A, Shah PS, Sankaran K, Seshia MM, Yee W, Jefferies A, Lee SK (2012) Neonatal outcomes of small for gestational age preterm infants in Canada. Am J Perinatol 29(2):87–94PubMedCrossRef

16.

Langston C, Kida K, Reed M, Thurlbeck WM (1984) Human lung growth in late gestation and in the neonate. Am Rev Respir Dis 129:607–613PubMed

17.

Bose C, Van Marter LJ, Laughon M, O’Shea TM, Allred EN, Karna P, Ehrenkranz RA, Boggess K, Leviton A (2009) Fetal growth restriction and chronic lung disease among infants born before the 28th week of gestation. Pediatrics 124:e450–e458PubMedCrossRef

18.

Grisaru-Granovsky S, Reichman B, Lerner-Geva L, Boyko V, Hammerman C, Samueloff A, Schimmel MS (2012) Mortality and morbidity in preterm small-for-gestational-age infants: a population-based study. Am J Obstet Gynecol 206:150–157PubMedCrossRef

19.

Carey MA, Card JW, Voltz JW, Germolec DR, Korach KS, Zeldin DC (2007) The impact of sex and sex hormones on lung physiology and disease: lessons from animal studies. Am J Physiol Lung Cell Mol Physiol 293:L272–L278PubMedCrossRef

20.

Fleisher B, Kulovich MV, Hallman M, Gluck L (1985) Lung profile: sex differences in normal pregnancy. Obstet Gynecol 66:327–330PubMed

21.

Nielsen HC, Kirk WO, Sweezey N, Torday JS (1990) Coordination of growth and differentiation in the fetal lung. Exp Cell Res 188:89–96PubMedCrossRef

22.

Dammann CE, Ramadurai SM, McCants DD, Pham LD, Nielsen HC (2000) Androgen regulation of signaling pathways in late fetal mouse lung development. Endocrinology 141:2923–2929PubMedCrossRef

23.

Khosla SS, Gobran LI, Rooney SA (1980) Stimulation of phosphatidylcholine synthesis by 17 beta-estradiol in fetal rabbit lung. Biochim Biophys Acta 617:282–290PubMedCrossRef

24.

Khosla SS, Smith GJ, Parks PA, Rooney SA (1981) Effects of estrogen on fetal rabbit lung maturation: morphological and biochemical studies. Pediatr Res 15:1274–1281PubMedCrossRef

25.

Khosla SS, Rooney SA (1979) Stimulation of fetal lung surfactant production by administration of 17beta-estradiol to the maternal rabbit. Am J Obstet Gynecol 133:213–216PubMed

26.

Dani C, Reali MF, Bertini G, Wiechmann L, Spagnolo A, Tangucci M, Rubaltelli FF (1999) Risk factors for the development of respiratory distress syndrome and transient tachypnoea in newborn infants. Italian Group of Neonatal Pneumology. Eur Respir J 14:155–159PubMedCrossRef

27.

Henderson-Smart DJ, Hutchinson JL, Donoghue DA, Evans NJ, Simpson JM, Wright I (2006) Prenatal predictors of chronic lung disease in very preterm infants. Arch Dis Child Fetal Neonatal Ed 91:F40–F45PubMedCrossRef

28.

Parker RA, Lindstrom DP, Cotton RB (1996) Evidence from twin study implies possible genetic susceptibility to bronchopulmonary dysplasia. Semin Perinatol 20:206–209PubMedCrossRef

29.

Bhandari V, Bizzarro MJ, Shetty A, Zhong X, Page GP, Zhang H, Ment LR, Gruen JR (2006) Familial and genetic susceptibility to major neonatal morbidities in preterm twins. Pediatrics 117:1901–1906PubMedCrossRef

30.

Warner BB, Stuart LA, Papes RA, Wispe JR (1998) Functional and pathological effects of prolonged hyperoxia in neonatal mice. Am J Physiol 275:L110–L117PubMed

31.

Dauger S, Ferkdadji L, Saumon G, Vardon G, Peuchmaur M, Gaultier C, Gallego J (2003) Neonatal exposure to 65 % oxygen durably impairs lung architecture and breathing pattern in adult mice. Chest 123:530–538PubMedCrossRef

32.

Deng H, Mason SN, Auten RL Jr (2000) Lung inflammation in hyperoxia can be prevented by antichemokine treatment in newborn rats. Am J Respir Crit Care Med 162:2316–2323PubMedCrossRef

33.

Auten RL Jr, Mason SN, Tanaka DT, Welty-Wolf K, Whorton MH (2001) Anti-neutrophil chemokine preserves alveolar development in hyperoxia-exposed newborn rats. Am J Physiol Lung Cell Mol Physiol 281:L336–L344PubMed

34.

Coalson JJ (1997) Experimental models of bronchopulmonary dysplasia. Biol Neonate 71(Suppl 1):35–38PubMed

35.

Supplemental therapeutic oxygen for prethreshold retinopathy of prematurity (STOP-ROP), a randomized, controlled trial. I: primary outcomes (2000) Pediatrics 105:295–310

36.

Kinnula VL, Crapo JD, Raivio KO (1995) Generation and disposal of reactive oxygen metabolites in the lung. Lab Invest 73:3–19PubMed

37.

Freeman BA, Crapo JD (1982) Biology of disease: free radicals and tissue injury. Lab Invest 47:412–426PubMed

38.

Welty SE, Smith CV (2001) Rationale for antioxidant therapy in premature infants to prevent bronchopulmonary dysplasia. Nutr Rev 59:10–17PubMedCrossRef

39.

Welty SE (2003) Antioxidants and oxidations in bronchopulmonary dysplasia: there are no easy answers. J Pediatr 143:697–698PubMedCrossRef

40.

Asikainen TM, White CW (2004) Pulmonary antioxidant defenses in the preterm newborn with respiratory distress and bronchopulmonary dysplasia in evolution: implications for antioxidant therapy. Antioxid Redox Signal 6:155–167PubMedCrossRef

41.

Albertine KH, Jones GP, Starcher BC, Bohnsack JF, Davis PL, Cho SC, Carlton DP, Bland RD (1999) Chronic lung injury in preterm lambs. Disordered respiratory tract development. Am J Respir Crit Care Med 159:945–958PubMedCrossRef

42.

Ikegami M, Jobe AH (2002) Injury responses to different surfactants in ventilated premature lamb lungs. Pediatr Res 51:689–695PubMedCrossRef

43.

De Paepe ME, Greco D, Mao Q (2010) Angiogenesis-related gene expression profiling in ventilated preterm human lungs. Exp Lung Res 36:399–410PubMedCrossRef

44.

Wada K, Jobe AH, Ikegami M (1997) Tidal volume effects on surfactant treatment responses with the initiation of ventilation in preterm lambs. J Appl Physiol 83:1054–1061PubMed

45.

Naik AS, Kallapur SG, Bachurski CJ, Jobe AH, Michna J, Kramer BW, Ikegami M (2001) Effects of ventilation with different positive end-expiratory pressures on cytokine expression in the preterm lamb lung. Am J Respir Crit Care Med 164:494–498PubMedCrossRef

46.

Davis JM, Dickerson B, Metlay L, Penney DP (1991) Differential effects of oxygen and barotrauma on lung injury in the neonatal piglet. Pediatr Pulmonol 10:157–163PubMedCrossRef

47.

Van Marter LJ, Allred EN, Pagano M, Sanocka U, Parad R, Moore M, Susser M, Paneth N, Leviton A (2000) Do clinical markers of barotrauma and oxygen toxicity explain interhospital variation in rates of chronic lung disease? The neonatology committee for the developmental network. Pediatrics 105:1194–1201PubMedCrossRef

48.

Subramaniam P, Henderson-Smart DJ, Davis PG (2005) Prophylactic nasal continuous positive airways pressure for preventing morbidity and mortality in very preterm infants. Cochrane Database Syst Rev CD001243

49.

Morley CJ, Davis PG, Doyle LW, Brion LP, Hascoet JM, Carlin JB (2008) Nasal CPAP or intubation at birth for very preterm infants. N Engl J Med 358:700–708PubMedCrossRef

50.

Sandri F, Plavka R, Ancora G, Simeoni U, Stranak Z, Martinelli S, Mosca F, Nona J, Thomson M, Verder H, Fabbri L, Halliday H (2010) Prophylactic or early selective surfactant combined with nCPAP in very preterm infants. Pediatrics 125:e1402–e1409PubMedCrossRef

51.

Finer NN, Carlo WA, Walsh MC, Rich W, Gantz MG, Laptook AR, Yoder BA, Faix RG, Das A, Poole WK, Donovan EF, Newman NS, Ambalavanan N, Frantz ID III, Buchter S, Sanchez PJ, Kennedy KA, Laroia N, Poindexter BB, Cotten CM, Van Meurs KP, Duara S, Narendran V, Sood BG, O’Shea TM, Bell EF, Bhandari V, Watterberg KL, Higgins RD (2010) Early CPAP versus surfactant in extremely preterm infants. N Engl J Med 362:1970–1979PubMedCrossRef

52.

Stevens TP, Harrington EW, Blennow M, Soll RF (2007) Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. Cochrane Database Syst Rev CD003063

53.

Hernandez-Ronquillo L, Tellez-Zenteno JF, Weder-Cisneros N, Salinas-Ramirez V, Zapata-Pallagi JA, da SO (2004) Risk factors for the development of bronchopulmonary dysplasia: a case-control study. Arch Med Res 35:549–553PubMedCrossRef

54.

Zhang H, Fang J, Su H, Chen M (2011) Risk factors for bronchopulmonary dysplasia of neonates born at ≤1500 g of birth weight (1999–2009). Pediatr, Int

55.

Saugstad OD (2003) Bronchopulmonary dysplasia-oxidative stress and antioxidants. Semin Neonatol 8:39–49PubMedCrossRef

56.

Lahra MM, Jeffery HE (2004) A fetal response to chorioamnionitis is associated with early survival after preterm birth. Am J Obstet Gynecol 190:147–151PubMedCrossRef

57.

Yoon BH, Romero R, Jun JK, Park KH, Park JD, Ghezzi F, Kim BI (1997) Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8) and the risk for the development of bronchopulmonary dysplasia. Am J Obstet Gynecol 177:825–830PubMedCrossRef

58.

Hannaford K, Todd DA, Jeffery H, John E, Blyth K, Gilbert GL (1999) Role of ureaplasma urealyticum in lung disease of prematurity. Arch Dis Child Fetal Neonatal Ed 81:F162–F167PubMedCrossRef

59.

Viscardi RM, Hasday JD (2009) Role of ureaplasma species in neonatal chronic lung disease: epidemiologic and experimental evidence. Pediatr Res 65:84R–90RPubMedCrossRef

60.

Hartling L, Liang Y, Lacaze-Masmonteil T (2012) Chorioamnionitis as a risk factor for bronchopulmonary dysplasia: a systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed 97(1):F8–F17PubMedCrossRef

61.

Lahra MM, Beeby PJ, Jeffery HE (2009) Intrauterine inflammation, neonatal sepsis, and chronic lung disease: a 13-year hospital cohort study. Pediatrics 123:1314–1319PubMedCrossRef

62.

Jobe AH (2012) What is BPD in 2012 and what will BPD become? Early Hum Dev 88(Suppl 2):S27–S28PubMedCrossRef

63.

Horbar JD, Badger GJ, Carpenter JH, Fanaroff AA, Kilpatrick S, LaCorte M, Phibbs R, Soll RF (2002) Trends in mortality and morbidity for very low birth weight infants, 1991–1999. Pediatrics 110:143–151PubMedCrossRef

64.

Wheeler KI, Klingenberg C, Morley CJ, Davis PG (2011) Volume-targeted versus pressure-limited ventilation for preterm infants: a systematic review and meta-analysis. Neonatology 100:219–227PubMedCrossRef

65.

Morley CJ (2012) Volume-limited and volume-targeted ventilation. Clin Perinatol 39:513–523PubMedCrossRef

66.

Miller JD, Carlo WA (2007) Safety and effectiveness of permissive hypercapnia in the preterm infant. Curr Opin Pediatr 19:142–144PubMedCrossRef

67.

Askie LM, Henderson-Smart DJ, Irwig L, Simpson JM (2003) Oxygen-saturation targets and outcomes in extremely preterm infants. N Engl J Med 349:959–967PubMedCrossRef

68.

Carlo WA, Finer NN, Walsh MC, Rich W, Gantz MG, Laptook AR, Yoder BA, Faix RG, Das A, Poole WK, Schibler K, Newman NS, Ambalavanan N, Frantz ID III, Piazza AJ, Sanchez PJ, Morris BH, Laroia N, Phelps DL, Poindexter BB, Cotten CM, Van Meurs KP, Duara S, Narendran V, Sood BG, O’Shea TM, Bell EF, Ehrenkranz RA, Watterberg KL, Higgins RD (2010) Target ranges of oxygen saturation in extremely preterm infants. N Engl J Med 362:1959–1969PubMedCrossRef

69.

Watterberg KL (1995) Evidence of early adrenal insufficiency in babies who develop bronchopulmonary dysplasia. Pediatrics 95:120–125PubMed

70.

Yoder MC Jr, Chua R, Tepper R (1991) Effect of dexamethasone on pulmonary inflammation and pulmonary function of ventilator-dependent infants with bronchopulmonary dysplasia. Am Rev Respir Dis 143:1044–1048PubMedCrossRef

71.

Halliday HL, Ehrenkranz RA, Doyle LW (2009) Late (>7 days) postnatal corticosteroids for chronic lung disease in preterm infants. Cochrane Database Syst Rev CD001145

72.

Halliday HL, Ehrenkranz RA, Doyle LW (2010) Early (<8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database Syst Rev CD001146

73.

Shah SS, Ohlsson A, Halliday H, Shah VS (2007) Inhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infants. Cochrane Database Syst Rev CD002057

74.

Shah V, Ohlsson A, Halliday HL, Dunn MS (2007) Early administration of inhaled corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates. Cochrane Database Syst Rev CD001969

75.

Lister P, Iles R, Shaw BNj, Ducharme FM (2010) Withdrawn. Inhaled steroids for neonatal chronic lung disease. Cochrane Database Syst CD002311

76.

National Institutes of Health Consensus Development Conference on Infantile Apnea and Home Monitoring, Sept 29 to Oct 1, 1986 (1987) Pediatrics 79:292–299

77.

Henderson-Smart DJ, Steer P (2001) Methylxanthine treatment for apnea in preterm infants. Cochrane Database Syst Rev CD000140

78.

Henderson-Smart DJ, De Paoli AG (2010) Methylxanthine treatment for apnoea in preterm infants. Cochrane Database Syst Rev CD000140

79.

Schmidt B, Roberts RS, Davis P, Doyle LW, Barrington KJ, Ohlsson A, Solimano A, Tin W (2006) Caffeine therapy for apnea of prematurity. N Engl J Med 354:2112–2121PubMedCrossRef

80.

Schmidt B, Roberts R, Millar D, Kirpalani H (2008) Evidence-based neonatal drug therapy for prevention of bronchopulmonary dysplasia in very-low-birth-weight infants. Neonatology 93:284–287PubMedCrossRef

81.

Shenai JP, Chytil F, Stahlman MT (1985) Vitamin A status of neonates with bronchopulmonary dysplasia. Pediatr Res 19:185–188PubMedCrossRef

82.

Wolbach SB, Howe PR (1933) Epithelial repair in recovery from vitamin a deficiency: an experimental study. J Exp Med 57:511–526PubMedCrossRef

83.

Wolbach SB, Howe PR (1925) Tissue changes following deprivation of fat-soluble a vitamin. J Exp Med 42:753–777PubMedCrossRef

84.

Tyson JE, Wright LL, Oh W, Kennedy KA, Mele L, Ehrenkranz RA, Stoll BJ, Lemons JA, Stevenson DK, Bauer CR, Korones SB, Fanaroff AA (1999) Vitamin A supplementation for extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. N Engl J Med 340:1962–1968PubMedCrossRef

85.

Darlow BA, Graham PJ (2007) Vitamin A supplementation to prevent mortality and short and long-term morbidity in very low birthweight infants. Cochrane Database Syst Rev CD000501

86.

Crowley PA (1995) Antenatal corticosteroid therapy: a meta-analysis of the randomized trials, 1972 to 1994. Am J Obstet Gynecol 173:322–335PubMedCrossRef

87.

Jobe AH (2003) Antenatal factors and the development of bronchopulmonary dysplasia. Semin Neonatol 8:9–17PubMedCrossRef

88.

Johnson JW, Mitzner W, Beck JC, London WT, Sly DL, Lee PA, Khouzami VA, Cavalieri RL (1981) Long-term effects of betamethasone on fetal development. Am J Obstet Gynecol 141:1053–1064PubMed

89.

Johnson JW, Mitzner W, London WT, Palmer AE, Scott R, Kearney K (1978) Glucocorticoids and the rhesus fetal lung. Am J Obstet Gynecol 130:905–916PubMed

90.

Soll RF, Morley CJ (2001) Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev CD000510

91.

Yost CC, Soll RF (2000) Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. Cochrane Database Syst Rev CD001456

92.

Blau HM, Brazelton TR, Weimann JM (2001) The evolving concept of a stem cell: entity or function? Cell 105:829–841PubMedCrossRef

93.

Alphonse RS, Thebaud B (2011) Growth factors, stem cells and bronchopulmonary dysplasia. Neonatology 99:326–337PubMedCrossRef

94.

Abman SH, Matthay MA (2009) Mesenchymal stem cells for the prevention of bronchopulmonary dysplasia: delivering the secretome. Am J Respir Crit Care Med 180:1039–1041PubMedCrossRef

95.

Short EJ, Klein NK, Lewis BA, Fulton S, Eisengart S, Kercsmar C, Baley J, Singer LT (2003) Cognitive and academic consequences of bronchopulmonary dysplasia and very low birth weight: 8-year-old outcomes. Pediatrics 112:e359PubMedCrossRef

96.

Lewis BA, Singer LT, Fulton S, Salvator A, Short EJ, Klein N, Baley J (2002) Speech and language outcomes of children with bronchopulmonary dysplasia. J Commun Disord 35:393–406PubMedCrossRef

97.

Short EJ, Kirchner HL, Asaad GR, Fulton SE, Lewis BA, Klein N, Eisengart S, Baley J, Kercsmar C, Min MO, Singer LT (2007) Developmental sequelae in preterm infants having a diagnosis of bronchopulmonary dysplasia: analysis using a severity-based classification system. Arch Pediatr Adolesc Med 161:1082–1087PubMedCrossRef

98.

Vrijlandt EJ, Boezen HM, Gerritsen J, Stremmelaar EF, Duiverman EJ (2007) Respiratory health in prematurely born preschool children with and without bronchopulmonary dysplasia. J Pediatr 150:256–261PubMedCrossRef

99.

Halvorsen T, Skadberg BT, Eide GE, Roksund OD, Carlsen KH, Bakke P (2004) Pulmonary outcome in adolescents of extreme preterm birth: a regional cohort study. Acta Paediatr 93:1294–1300PubMedCrossRef

100.

Vrijlandt EJ, Gerritsen J, Boezen HM, Duiverman EJ (2005) Gender differences in respiratory symptoms in 19-year-old adults born preterm. Respir Res 6:117PubMedCrossRef

101.

Teune MJ, van Wassenaer AG, van BS, Mol BW, Opmeer BC (2012) Perinatal risk-indicators for long-term respiratory morbidity among preterm or very low birth weight neonates. Eur J Obstet Gynecol Reprod Biol 163:134–141PubMedCrossRef

102.

Kajantie E, Strang-Karlsson S, Hovi P, Raikkonen K, Pesonen AK, Heinonen K, Jarvenpaa AL, Eriksson JG, Andersson S (2010) Adults born at very low birth weight exercise less than their peers born at term. J Pediatr 157(610–6):616

103.

Decramer M, Rennard S, Troosters T, Mapel DW, Giardino N, Mannino D, Wouters E, Sethi S, Cooper CB (2008) COPD as a lung disease with systemic consequences—clinical impact, mechanisms, and potential for early intervention. COPD. 5:235–256PubMedCrossRef

Title: Bronchopulmonary dysplasia: a review
Authors: Zarqa Ali
Peter Schmidt
James Dodd
Dorthe Lisbeth Jeppesen
Publication date: 01-08-2013
Publisher: Springer Berlin Heidelberg
Published in: Archives of Gynecology and Obstetrics / Issue 2/2013
Print ISSN: 0932-0067
Electronic ISSN: 1432-0711
DOI: https://doi.org/10.1007/s00404-013-2753-8

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Bronchopulmonary dysplasia: a review

Abstract

Introduction

Methods

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Introduction

Methods

Conclusion

Please log in to get access to this content

Other articles of this Issue 2/2013

New mini-resectoscope: analysis of preliminary quality results in outpatient hysteroscopic polypectomy

Early amniotomy after vaginal misoprostol for induction of labor: a randomized clinical trial

Fetal uvula: navigating and lightening the soft palate using HDlive

Letrozole usage adjuvant to gonadotropins for ovulation induction for patients with clomiphene citrate failure

Erratum to: Analysis of the impact of PAPP-A, free β-hCG and nuchal translucency thickness on the advanced first trimester screening

Disruption of precise regulation of αPKC expression and cellular localization is associated with cervical cancer progression